Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

873
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
873
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

360
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

929
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
929
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

630
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
630
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissection of the interventricular septum: Echocardiographic features.

Medicine·2017
Same author

Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial Heart.

Journal of cardiac failure·2016
Same author

Echocardiographic versus histologic findings in Marfan syndrome.

Texas Heart Institute journal·2015
Same author

Clinical indications for implantation of the total artificial heart.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2014
Same author

Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association.

Circulation·2014
Same author

Intracardiac leiomyomatosis: clinical findings and detailed echocardiographic features--a Chinese institutional experience.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2014

Related Experiment Video

Updated: Apr 30, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

6.2K

Endocarditis 2014: an update.

Kristin L Thanavaro1, J V Ian Nixon1

  • 1Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Heart & Lung : the Journal of Critical Care
|May 1, 2014
PubMed
Summary

Infective endocarditis epidemiology is shifting due to antibiotic use, resistant microbes, and device implants. Guidelines now restrict prophylaxis to high-risk patients, impacting cardiovascular device infection management.

Keywords:
Cardiac device infectionsCardiac valve diseaseEndocarditis

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

8.6K
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

6.2K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

8.6K
Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

1.4K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The epidemiology of infective endocarditis (IE) is evolving.
  • Factors include increased antibiotic use, emerging resistant microorganisms, and rising cardiovascular device implantation.
  • Cardiovascular device-related infections (CVDRIs) present significant morbidity and mortality, particularly in older populations.

Purpose of the Study:

  • To review and consolidate recent guidelines for IE prevention and management.
  • To outline strategies for managing cardiovascular device infections.
  • To summarize evidence-based guidelines for treating CVDRIs.

Main Methods:

  • Review of recent guidelines, including AHA/ACC (2007, 2010) and HRS (2009) consensus documents.
  • Consolidation of scientific statements on IE prevention, management, and CVDRIs.
  • Analysis of evidence-based recommendations for patient care.

Main Results:

  • Endocarditis prophylaxis is now recommended only for specific high-risk groups: prosthetic valves, prior IE, cardiac transplant recipients with valvulopathy, and certain congenital heart disease patients.
  • There is an increasing incidence of CVDRIs.
  • Older patients with implanted devices face higher morbidity and mortality rates.

Conclusions:

  • Current guidelines have narrowed the criteria for IE prophylaxis.
  • The management of CVDRIs requires careful consideration due to increasing incidence and patient risk.
  • Updated guidelines are crucial for optimizing patient outcomes in the context of changing IE epidemiology.